BB-29-VD14_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, N-(4-bromo-2,6-dimethylphenyl)hexanamide, Voltage-Gated K(V) 7.2 (KCNQ2) Channel Activators targeting KCNQ2, KCNQ3 (Novartis, 3601868)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/3601868
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the BB-29-VD14_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
EIF4E2 eukaryotic translation initiation factor 4E family member 2 1.45956
TNRC18 trinucleotide repeat containing 18 0.523086
MANBAL mannosidase, beta A, lysosomal-like 0.490797
SF3B6 splicing factor 3b, subunit 6, 14kDa 0.365154
EIF3M eukaryotic translation initiation factor 3, subunit M 0.326261
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.294896
RRM2 ribonucleotide reductase M2 0.28988

decreased expression

Symbol Name Standardized Value
NFKBIE nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon -0.641028
TGIF1 TGFB-induced factor homeobox 1 -0.277532
TFPT TCF3 (E2A) fusion partner (in childhood Leukemia) -0.266946
RPAP1 RNA polymerase II associated protein 1 -0.225261
STOM stomatin -0.220956
RNF8 ring finger protein 8, E3 ubiquitin protein ligase -0.218005
RUSC1 RUN and SH3 domain containing 1 -0.205849